Clinical Trial Update: Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of Lysteda (tranexamic acid) in adolescent females with heavy menstrual bleeding (menorrhagia); results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia

Drugs mentioned

• Lysteda (tranexamic acid)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Menorrhagia | Phase 4 | Status: COMPLETED | Results posted: 2012-07-03